New Generic Drug Market Reports by IMARC Group Now Available at MarketPublishers.com14 Jun 2016 • by Natalie Aster
LONDON – MarketPublishers.com is very happy to announce that now you can find new generic drug market studies by IMARC Group in its online catalogue.
Japan is the number 8 in the list of the world’s largest generic drug markets in terms of value. However, penetration of such drugs has been traditionally low in this country if compared to such developed markets like Europe and the USA. Landscape of this market has undergone noticeable changes over the last 10 years given support provided by the country’s government. In Japan, drug costs hold and around 20% share of total medical expenses. The government intends to reach a generic penetration of 60% by early 2017. This plan is expected to create great opportunities for foreign as well as domestic generic manufacturers operating in this country…
In the USA, this market has experienced significant transformation over the last few decades. Initially, generic drugs accounted more approximately 20% of total prescriptions being dispensed in the country. Now they hold the lion’s share of prescriptions in the USA. The local marketplace grew at an 11% CAGR over the period 2010-2015 and now it is a multibillion industry. Lower prices for such products act a top driving force for this market. Blockbuster drugs’ patent expiration, growing prevalence of chronic disease as well as population ageing also encourage the growth. Teva, Sandoz, Mylan are amongst companies dominating the space…
Canada forms the 9th largest market globally in terms of value. The drugs' use and acceptance have undergone significant changes over the last several decades. This marketplace is a very lucrative for both domestic and overseas players. This can be attributed to population ageing, growth in prevalence of chronic diseases, existence of a considerable drug difference between generic drugs and branded ones, to name a few. This evolving marketplace is ruled by such companies as Hospira, Actavis, Apotex, Novartis, and more…
- insightful overview of each marketplace;
- coverage of latest trends and developments;
- insights into a market structure;
- coverage of a manufacturing process;
- investigation of the competitive landscape;
- information on value chain;
- data on pricing mechanisms;
- exploration of the regulatory framework;
- and more.
More new studies by this publisher are available at IMARC Group page.